 Robert Enzenauer
Concepts (542)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amblyopia | 7 | 2023 | 8 | 1.880 |
Why?
| | Ophthalmologic Surgical Procedures | 8 | 2019 | 58 | 1.590 |
Why?
| | Vision Screening | 4 | 2023 | 9 | 1.570 |
Why?
| | Retinopathy of Prematurity | 9 | 2021 | 141 | 1.450 |
Why?
| | Strabismus | 9 | 2017 | 29 | 1.290 |
Why?
| | Refractive Errors | 4 | 2023 | 18 | 1.240 |
Why?
| | Oculomotor Muscles | 11 | 2017 | 40 | 1.200 |
Why?
| | Cornea | 9 | 2021 | 137 | 1.150 |
Why?
| | Ophthalmology | 6 | 2021 | 86 | 0.870 |
Why?
| | Eye Injuries, Penetrating | 3 | 2013 | 19 | 0.800 |
Why?
| | Military Medicine | 4 | 2016 | 63 | 0.770 |
Why?
| | Military Personnel | 8 | 2018 | 544 | 0.730 |
Why?
| | Eye Injuries | 8 | 2016 | 45 | 0.710 |
Why?
| | Eye Foreign Bodies | 3 | 2014 | 25 | 0.690 |
Why?
| | Photography | 3 | 2010 | 95 | 0.670 |
Why?
| | Endophthalmitis | 5 | 2002 | 29 | 0.650 |
Why?
| | Chemical Warfare Agents | 6 | 2021 | 114 | 0.630 |
Why?
| | Exotropia | 4 | 2006 | 5 | 0.620 |
Why?
| | Patient Simulation | 1 | 2019 | 35 | 0.610 |
Why?
| | Lighting | 2 | 2016 | 26 | 0.590 |
Why?
| | Tensile Strength | 2 | 2017 | 97 | 0.580 |
Why?
| | Amnion | 1 | 2017 | 28 | 0.560 |
Why?
| | Equipment Design | 1 | 2019 | 521 | 0.540 |
Why?
| | Eye Infections, Bacterial | 3 | 2002 | 28 | 0.530 |
Why?
| | Down Syndrome | 1 | 2023 | 490 | 0.530 |
Why?
| | Teaching | 1 | 2019 | 224 | 0.520 |
Why?
| | Esotropia | 4 | 2006 | 8 | 0.520 |
Why?
| | Diagnostic Techniques, Ophthalmological | 3 | 2016 | 39 | 0.510 |
Why?
| | Color Vision | 1 | 2016 | 3 | 0.500 |
Why?
| | Wound Healing | 3 | 2017 | 328 | 0.490 |
Why?
| | Color | 1 | 2016 | 77 | 0.490 |
Why?
| | Neonatal Screening | 5 | 2021 | 169 | 0.460 |
Why?
| | Delivery of Health Care | 2 | 2013 | 935 | 0.440 |
Why?
| | Boxing | 5 | 1994 | 6 | 0.430 |
Why?
| | Ophthalmic Solutions | 5 | 2017 | 75 | 0.430 |
Why?
| | Tissue Adhesions | 2 | 2017 | 32 | 0.420 |
Why?
| | Humans | 117 | 2023 | 136803 | 0.410 |
Why?
| | Visual Acuity | 11 | 2013 | 348 | 0.410 |
Why?
| | Surgical Procedures, Operative | 1 | 2016 | 258 | 0.400 |
Why?
| | Vitrectomy | 4 | 2007 | 70 | 0.400 |
Why?
| | Retinoscopes | 1 | 2011 | 1 | 0.360 |
Why?
| | Insurance, Liability | 1 | 2010 | 6 | 0.340 |
Why?
| | Dacryocystitis | 1 | 2010 | 3 | 0.340 |
Why?
| | Rabbits | 8 | 2021 | 792 | 0.340 |
Why?
| | Mucocele | 1 | 2010 | 12 | 0.340 |
Why?
| | Nonprescription Drugs | 2 | 2003 | 63 | 0.340 |
Why?
| | Pupil Disorders | 1 | 2010 | 5 | 0.330 |
Why?
| | Infant, Newborn | 27 | 2021 | 6032 | 0.330 |
Why?
| | Mustard Gas | 3 | 2021 | 103 | 0.330 |
Why?
| | Corneal Injuries | 2 | 2021 | 44 | 0.320 |
Why?
| | Conjunctival Diseases | 2 | 2017 | 18 | 0.320 |
Why?
| | Reimbursement Mechanisms | 1 | 2010 | 84 | 0.320 |
Why?
| | Warfare | 3 | 2018 | 68 | 0.320 |
Why?
| | Sensitivity and Specificity | 6 | 2023 | 1936 | 0.310 |
Why?
| | Decompression, Surgical | 3 | 2019 | 102 | 0.300 |
Why?
| | Surveys and Questionnaires | 8 | 2021 | 5744 | 0.300 |
Why?
| | Mechlorethamine | 3 | 2019 | 60 | 0.300 |
Why?
| | Corneal Neovascularization | 3 | 2017 | 15 | 0.290 |
Why?
| | Developmental Disabilities | 1 | 2011 | 262 | 0.280 |
Why?
| | Vitreous Detachment | 1 | 2007 | 9 | 0.280 |
Why?
| | Optic Neuropathy, Ischemic | 1 | 2007 | 30 | 0.280 |
Why?
| | Optic Disk | 1 | 2007 | 44 | 0.270 |
Why?
| | Vitreous Body | 1 | 2007 | 110 | 0.260 |
Why?
| | Circumcision, Male | 5 | 1987 | 14 | 0.260 |
Why?
| | Arsenicals | 2 | 2017 | 30 | 0.260 |
Why?
| | Birth Weight | 5 | 2017 | 514 | 0.260 |
Why?
| | Weight Gain | 3 | 2016 | 519 | 0.260 |
Why?
| | Photorefractive Keratectomy | 1 | 2006 | 19 | 0.250 |
Why?
| | Infant | 25 | 2017 | 9395 | 0.250 |
Why?
| | Horner Syndrome | 1 | 2006 | 3 | 0.250 |
Why?
| | Choristoma | 1 | 2006 | 21 | 0.250 |
Why?
| | Orbit | 3 | 2013 | 70 | 0.250 |
Why?
| | Corneal Transplantation | 2 | 2005 | 13 | 0.240 |
Why?
| | Indans | 1 | 2005 | 11 | 0.240 |
Why?
| | Glaucoma, Angle-Closure | 1 | 2005 | 17 | 0.240 |
Why?
| | Nootropic Agents | 1 | 2005 | 27 | 0.240 |
Why?
| | Neck | 1 | 2006 | 101 | 0.240 |
Why?
| | Cataract Extraction | 3 | 2002 | 98 | 0.240 |
Why?
| | Hypergammaglobulinemia | 2 | 1999 | 9 | 0.240 |
Why?
| | Retinal Hemorrhage | 5 | 2013 | 19 | 0.240 |
Why?
| | Keratomileusis, Laser In Situ | 1 | 2005 | 21 | 0.230 |
Why?
| | Predictive Value of Tests | 3 | 2023 | 2022 | 0.230 |
Why?
| | Thymus Gland | 1 | 2006 | 313 | 0.230 |
Why?
| | Ocular Motility Disorders | 2 | 2003 | 27 | 0.220 |
Why?
| | Mathematical Computing | 1 | 2004 | 10 | 0.220 |
Why?
| | Vitamin A Deficiency | 1 | 2004 | 26 | 0.220 |
Why?
| | Contact Lenses, Hydrophilic | 2 | 1997 | 7 | 0.220 |
Why?
| | Multiple Sclerosis | 1 | 2010 | 455 | 0.220 |
Why?
| | Orbital Fractures | 1 | 2004 | 9 | 0.220 |
Why?
| | Vision, Ocular | 2 | 2016 | 38 | 0.220 |
Why?
| | Retinal Detachment | 2 | 2002 | 63 | 0.220 |
Why?
| | Child | 17 | 2023 | 21819 | 0.210 |
Why?
| | Piperidines | 1 | 2005 | 206 | 0.210 |
Why?
| | Corneal Diseases | 2 | 2015 | 34 | 0.210 |
Why?
| | Diplopia | 1 | 2003 | 19 | 0.200 |
Why?
| | Suture Techniques | 3 | 1999 | 121 | 0.200 |
Why?
| | Dry Eye Syndromes | 1 | 2003 | 54 | 0.200 |
Why?
| | Drug Costs | 1 | 2003 | 106 | 0.200 |
Why?
| | Risk Factors | 9 | 2023 | 10332 | 0.190 |
Why?
| | Eyelids | 3 | 2013 | 37 | 0.190 |
Why?
| | Astigmatism | 2 | 2011 | 10 | 0.190 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3265 | 0.190 |
Why?
| | Intraocular Pressure | 6 | 2013 | 305 | 0.190 |
Why?
| | Physical Examination | 1 | 2023 | 240 | 0.190 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2003 | 242 | 0.190 |
Why?
| | Granuloma, Foreign-Body | 1 | 2002 | 10 | 0.190 |
Why?
| | Male | 54 | 2020 | 67330 | 0.190 |
Why?
| | Blepharoptosis | 1 | 2002 | 11 | 0.190 |
Why?
| | Oculomotor Nerve Diseases | 1 | 2002 | 10 | 0.190 |
Why?
| | Sclerostomy | 1 | 2001 | 4 | 0.190 |
Why?
| | Female | 47 | 2017 | 72816 | 0.190 |
Why?
| | Abducens Nerve Diseases | 1 | 2002 | 12 | 0.190 |
Why?
| | Myopia | 2 | 2011 | 47 | 0.190 |
Why?
| | Epithelium, Corneal | 3 | 2017 | 41 | 0.180 |
Why?
| | Hospitalization | 3 | 2010 | 2184 | 0.180 |
Why?
| | Child, Preschool | 17 | 2020 | 10997 | 0.180 |
Why?
| | Echolalia | 1 | 2001 | 1 | 0.180 |
Why?
| | Vigabatrin | 1 | 2021 | 18 | 0.180 |
Why?
| | Aniridia | 1 | 2020 | 5 | 0.180 |
Why?
| | Lupus Vasculitis, Central Nervous System | 1 | 2001 | 11 | 0.180 |
Why?
| | PAX6 Transcription Factor | 1 | 2020 | 21 | 0.170 |
Why?
| | Tissue Donors | 2 | 2005 | 417 | 0.170 |
Why?
| | Trabeculectomy | 1 | 2001 | 72 | 0.170 |
Why?
| | Arthritis | 3 | 2017 | 95 | 0.170 |
Why?
| | Infant, Low Birth Weight | 2 | 2017 | 140 | 0.170 |
Why?
| | Retinal Diseases | 5 | 1994 | 91 | 0.170 |
Why?
| | Codon, Nonsense | 1 | 2020 | 44 | 0.170 |
Why?
| | Immunoglobulin G | 2 | 1999 | 887 | 0.170 |
Why?
| | Eye Proteins | 1 | 2020 | 92 | 0.170 |
Why?
| | Cyclooxygenase 2 | 5 | 2021 | 178 | 0.170 |
Why?
| | Glaucoma, Open-Angle | 1 | 2001 | 103 | 0.170 |
Why?
| | Socioeconomic Factors | 3 | 2021 | 1282 | 0.160 |
Why?
| | Leadership | 1 | 2004 | 382 | 0.160 |
Why?
| | Drug Residues | 1 | 1999 | 5 | 0.160 |
Why?
| | Scleral Buckling | 1 | 1999 | 18 | 0.160 |
Why?
| | Corneal Stroma | 2 | 2017 | 17 | 0.160 |
Why?
| | Sclera | 1 | 1999 | 36 | 0.160 |
Why?
| | Prospective Studies | 7 | 2019 | 7573 | 0.160 |
Why?
| | Wilms Tumor | 1 | 2020 | 86 | 0.160 |
Why?
| | Organ Preservation Solutions | 1 | 1999 | 45 | 0.160 |
Why?
| | Disease Models, Animal | 3 | 2019 | 4282 | 0.160 |
Why?
| | Postoperative Complications | 3 | 2017 | 2639 | 0.160 |
Why?
| | Lacrimal Apparatus | 1 | 2019 | 9 | 0.160 |
Why?
| | Immunoglobulin lambda-Chains | 1 | 1999 | 7 | 0.150 |
Why?
| | Paraproteinemias | 1 | 1999 | 5 | 0.150 |
Why?
| | Functional Laterality | 2 | 2010 | 223 | 0.150 |
Why?
| | Retinal Vein Occlusion | 1 | 1999 | 13 | 0.150 |
Why?
| | Anticonvulsants | 1 | 2021 | 215 | 0.150 |
Why?
| | Organ Preservation | 1 | 1999 | 102 | 0.150 |
Why?
| | Face | 1 | 2020 | 173 | 0.150 |
Why?
| | Contrast Sensitivity | 1 | 2018 | 14 | 0.150 |
Why?
| | Vision Tests | 1 | 2018 | 16 | 0.150 |
Why?
| | United States | 13 | 2021 | 14691 | 0.150 |
Why?
| | Color Perception | 1 | 2018 | 23 | 0.150 |
Why?
| | Pneumococcal Infections | 1 | 1999 | 115 | 0.150 |
Why?
| | Matrix Metalloproteinase 9 | 4 | 2021 | 132 | 0.150 |
Why?
| | Staphylococcal Infections | 3 | 2011 | 399 | 0.150 |
Why?
| | Adolescent | 16 | 2016 | 21385 | 0.140 |
Why?
| | Retrobulbar Hemorrhage | 2 | 2009 | 3 | 0.140 |
Why?
| | Naphazoline | 1 | 1997 | 1 | 0.140 |
Why?
| | Pheniramine | 1 | 1997 | 1 | 0.140 |
Why?
| | Gestational Age | 6 | 2017 | 902 | 0.140 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 87 | 0.140 |
Why?
| | Nasal Decongestants | 1 | 1997 | 8 | 0.140 |
Why?
| | Conjunctivitis, Allergic | 1 | 1997 | 4 | 0.140 |
Why?
| | Atropine | 1 | 2017 | 23 | 0.140 |
Why?
| | Histamine H1 Antagonists | 1 | 1997 | 30 | 0.140 |
Why?
| | Mydriasis | 1 | 1997 | 10 | 0.140 |
Why?
| | Nerve Agents | 1 | 2017 | 7 | 0.140 |
Why?
| | Athletic Injuries | 3 | 1989 | 526 | 0.140 |
Why?
| | Conjunctiva | 1 | 2017 | 51 | 0.140 |
Why?
| | Farber Lipogranulomatosis | 1 | 2017 | 4 | 0.140 |
Why?
| | Meningitis | 3 | 1983 | 79 | 0.140 |
Why?
| | Adult | 21 | 2018 | 37643 | 0.140 |
Why?
| | Antimetabolites | 1 | 1997 | 23 | 0.140 |
Why?
| | Synovitis | 1 | 2017 | 27 | 0.130 |
Why?
| | Drug Therapy, Combination | 5 | 2012 | 1062 | 0.130 |
Why?
| | Retrospective Studies | 15 | 2021 | 15510 | 0.130 |
Why?
| | Quality Indicators, Health Care | 1 | 1999 | 307 | 0.130 |
Why?
| | Cicatrix | 1 | 1997 | 64 | 0.130 |
Why?
| | Swine | 1 | 2019 | 773 | 0.130 |
Why?
| | Orbital Neoplasms | 2 | 1993 | 24 | 0.130 |
Why?
| | False Positive Reactions | 2 | 2011 | 115 | 0.130 |
Why?
| | Educational Measurement | 1 | 2019 | 280 | 0.130 |
Why?
| | Infant, Newborn, Diseases | 3 | 1982 | 113 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 576 | 0.130 |
Why?
| | Health Personnel | 2 | 2000 | 701 | 0.130 |
Why?
| | Kidney Neoplasms | 1 | 2020 | 401 | 0.120 |
Why?
| | Fluorouracil | 1 | 1997 | 210 | 0.120 |
Why?
| | Uveitis | 1 | 2017 | 134 | 0.120 |
Why?
| | Treatment Outcome | 10 | 2011 | 10748 | 0.120 |
Why?
| | Antidotes | 1 | 2017 | 143 | 0.120 |
Why?
| | Afghanistan | 2 | 2007 | 71 | 0.120 |
Why?
| | Visual Fields | 3 | 2007 | 90 | 0.120 |
Why?
| | Convergence, Ocular | 1 | 1995 | 6 | 0.120 |
Why?
| | Household Products | 1 | 2015 | 6 | 0.120 |
Why?
| | Eye Burns | 1 | 2015 | 12 | 0.120 |
Why?
| | Fibrosis | 1 | 2017 | 552 | 0.120 |
Why?
| | Algorithms | 3 | 2017 | 1690 | 0.110 |
Why?
| | Ethanol | 1 | 1999 | 606 | 0.110 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 316 | 0.110 |
Why?
| | Public Health | 1 | 2000 | 579 | 0.110 |
Why?
| | Burns, Chemical | 1 | 2015 | 32 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 6 | 2010 | 3556 | 0.110 |
Why?
| | Quality of Health Care | 1 | 1999 | 634 | 0.110 |
Why?
| | Animals | 9 | 2021 | 36850 | 0.110 |
Why?
| | Keratitis | 2 | 2017 | 15 | 0.110 |
Why?
| | Interleukin-8 | 3 | 2021 | 268 | 0.110 |
Why?
| | Slit Lamp | 1 | 2014 | 2 | 0.110 |
Why?
| | Hyphema | 1 | 2013 | 4 | 0.110 |
Why?
| | Vascular Endothelial Growth Factor A | 4 | 2019 | 543 | 0.110 |
Why?
| | Keratotomy, Radial | 1 | 1993 | 9 | 0.100 |
Why?
| | Lymphangioma | 1 | 1993 | 7 | 0.100 |
Why?
| | Blindness | 2 | 2009 | 38 | 0.100 |
Why?
| | Health Care Surveys | 2 | 2010 | 562 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2002 | 1033 | 0.100 |
Why?
| | Scleral Diseases | 1 | 1992 | 1 | 0.100 |
Why?
| | DNA Damage | 1 | 2016 | 420 | 0.100 |
Why?
| | Staphylococcus | 2 | 2011 | 76 | 0.100 |
Why?
| | Abducens Nerve | 1 | 1992 | 3 | 0.100 |
Why?
| | Eye Infections, Fungal | 1 | 1992 | 7 | 0.100 |
Why?
| | Skull Neoplasms | 1 | 1992 | 23 | 0.100 |
Why?
| | Dura Mater | 1 | 1992 | 31 | 0.100 |
Why?
| | Anesthetics, Dissociative | 1 | 2012 | 29 | 0.100 |
Why?
| | Opportunistic Infections | 1 | 1992 | 45 | 0.100 |
Why?
| | Hospitals, Military | 3 | 2007 | 25 | 0.100 |
Why?
| | Cranial Nerve Diseases | 1 | 1992 | 42 | 0.100 |
Why?
| | Biomarkers | 2 | 2021 | 4145 | 0.100 |
Why?
| | Doxycycline | 1 | 2012 | 62 | 0.100 |
Why?
| | Child Abuse | 3 | 2013 | 528 | 0.100 |
Why?
| | Glucocorticoids | 4 | 2017 | 593 | 0.090 |
Why?
| | Craniocerebral Trauma | 3 | 2013 | 167 | 0.090 |
Why?
| | Paralysis | 1 | 1992 | 70 | 0.090 |
Why?
| | Follow-Up Studies | 8 | 2011 | 5106 | 0.090 |
Why?
| | Ketamine | 1 | 2012 | 93 | 0.090 |
Why?
| | Foreign Bodies | 1 | 2013 | 104 | 0.090 |
Why?
| | Double-Blind Method | 2 | 2011 | 1982 | 0.090 |
Why?
| | Vision, Binocular | 4 | 2005 | 21 | 0.090 |
Why?
| | Cyclophosphamide | 2 | 2003 | 247 | 0.090 |
Why?
| | Anisometropia | 1 | 2011 | 1 | 0.090 |
Why?
| | Hyperopia | 1 | 2011 | 3 | 0.090 |
Why?
| | Middle Aged | 13 | 2016 | 33239 | 0.090 |
Why?
| | Orbital Cellulitis | 1 | 2011 | 17 | 0.090 |
Why?
| | Silymarin | 1 | 2012 | 199 | 0.090 |
Why?
| | Gingivitis | 1 | 1990 | 12 | 0.080 |
Why?
| | Facial Pain | 1 | 1990 | 12 | 0.080 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2013 | 249 | 0.080 |
Why?
| | Aged | 13 | 2016 | 23808 | 0.080 |
Why?
| | Retina | 3 | 2021 | 298 | 0.080 |
Why?
| | Corneal Keratocytes | 2 | 2021 | 9 | 0.080 |
Why?
| | Malpractice | 1 | 2010 | 45 | 0.080 |
Why?
| | Dexamethasone | 1 | 2012 | 368 | 0.080 |
Why?
| | Fat Emulsions, Intravenous | 1 | 1990 | 30 | 0.080 |
Why?
| | Light | 1 | 2013 | 378 | 0.080 |
Why?
| | Anti-Bacterial Agents | 4 | 2012 | 1798 | 0.080 |
Why?
| | Immunoglobulin Light Chains | 1 | 1990 | 47 | 0.080 |
Why?
| | Fluorescein Angiography | 4 | 1999 | 150 | 0.080 |
Why?
| | Retinal Vessels | 1 | 1990 | 69 | 0.080 |
Why?
| | Drug Industry | 1 | 1990 | 111 | 0.080 |
Why?
| | Incidental Findings | 1 | 2010 | 87 | 0.080 |
Why?
| | Aerospace Medicine | 3 | 2014 | 29 | 0.080 |
Why?
| | Anti-Infective Agents | 2 | 2002 | 254 | 0.080 |
Why?
| | Nocardia Infections | 1 | 1989 | 9 | 0.080 |
Why?
| | Incidence | 4 | 2013 | 2797 | 0.070 |
Why?
| | Corneal Ulcer | 2 | 2004 | 16 | 0.070 |
Why?
| | Blood Vessels | 2 | 2021 | 187 | 0.070 |
Why?
| | Color Perception Tests | 1 | 2007 | 3 | 0.070 |
Why?
| | Enteral Nutrition | 1 | 1990 | 201 | 0.070 |
Why?
| | Autopsy | 1 | 2007 | 93 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 400 | 0.070 |
Why?
| | Urinary Tract Infections | 2 | 1987 | 188 | 0.070 |
Why?
| | Sudden Infant Death | 1 | 2007 | 28 | 0.070 |
Why?
| | Eye Movements | 3 | 2005 | 67 | 0.070 |
Why?
| | Fundus Oculi | 6 | 1994 | 65 | 0.070 |
Why?
| | Prevalence | 2 | 2013 | 2710 | 0.070 |
Why?
| | Shaken Baby Syndrome | 1 | 2006 | 5 | 0.070 |
Why?
| | Accidents, Traffic | 2 | 2013 | 189 | 0.070 |
Why?
| | Immunosuppressive Agents | 2 | 2003 | 889 | 0.070 |
Why?
| | Chromosome Inversion | 1 | 1986 | 18 | 0.060 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2006 | 7 | 0.060 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 1986 | 55 | 0.060 |
Why?
| | Nasolacrimal Duct | 1 | 2006 | 8 | 0.060 |
Why?
| | Videotape Recording | 1 | 1986 | 35 | 0.060 |
Why?
| | Infant, Very Low Birth Weight | 2 | 2017 | 68 | 0.060 |
Why?
| | Lasers, Excimer | 1 | 2006 | 28 | 0.060 |
Why?
| | Time Factors | 4 | 2017 | 6809 | 0.060 |
Why?
| | Refraction, Ocular | 1 | 2006 | 37 | 0.060 |
Why?
| | Optic Nerve Diseases | 1 | 2006 | 38 | 0.060 |
Why?
| | Parenteral Nutrition, Total | 1 | 1985 | 26 | 0.060 |
Why?
| | Tomography, Optical Coherence | 1 | 2007 | 213 | 0.060 |
Why?
| | Health Surveys | 2 | 2006 | 513 | 0.060 |
Why?
| | Skin Diseases, Infectious | 1 | 1985 | 15 | 0.060 |
Why?
| | Chromosome Aberrations | 1 | 1986 | 155 | 0.060 |
Why?
| | Cell Survival | 2 | 2021 | 1116 | 0.060 |
Why?
| | Diagnosis, Differential | 2 | 2006 | 1481 | 0.060 |
Why?
| | Colorado | 4 | 2017 | 4515 | 0.060 |
Why?
| | Quality Control | 1 | 2006 | 171 | 0.060 |
Why?
| | Refractive Surgical Procedures | 1 | 2005 | 5 | 0.060 |
Why?
| | Adenocarcinoma | 1 | 1992 | 938 | 0.060 |
Why?
| | Smoking Prevention | 1 | 1986 | 183 | 0.060 |
Why?
| | Reoperation | 3 | 1999 | 573 | 0.060 |
Why?
| | Prostatic Neoplasms | 1 | 1992 | 1034 | 0.060 |
Why?
| | Pyoderma | 1 | 1984 | 2 | 0.060 |
Why?
| | Ethics | 1 | 2004 | 8 | 0.060 |
Why?
| | Night Blindness | 1 | 2004 | 6 | 0.060 |
Why?
| | Myxoma | 1 | 1984 | 12 | 0.060 |
Why?
| | Mitral Valve Stenosis | 1 | 1984 | 18 | 0.060 |
Why?
| | Xerophthalmia | 1 | 2004 | 7 | 0.060 |
Why?
| | Intellectual Disability | 1 | 1986 | 164 | 0.060 |
Why?
| | Organizational Objectives | 1 | 2004 | 73 | 0.050 |
Why?
| | Heart Neoplasms | 1 | 1984 | 50 | 0.050 |
Why?
| | Chloramphenicol | 1 | 1983 | 9 | 0.050 |
Why?
| | Ampicillin | 1 | 1983 | 13 | 0.050 |
Why?
| | Theophylline | 1 | 1984 | 67 | 0.050 |
Why?
| | Esophageal Diseases | 1 | 1984 | 28 | 0.050 |
Why?
| | Data Interpretation, Statistical | 1 | 2006 | 363 | 0.050 |
Why?
| | Disability Evaluation | 1 | 2005 | 290 | 0.050 |
Why?
| | Tobacco Smoke Pollution | 1 | 1986 | 261 | 0.050 |
Why?
| | Preservatives, Pharmaceutical | 1 | 2003 | 26 | 0.050 |
Why?
| | Anti-Inflammatory Agents | 2 | 2012 | 496 | 0.050 |
Why?
| | Syndrome | 3 | 2020 | 357 | 0.050 |
Why?
| | Drug Packaging | 1 | 2003 | 45 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2019 | 1733 | 0.050 |
Why?
| | Corneal Opacity | 2 | 2016 | 7 | 0.050 |
Why?
| | Pleura | 1 | 1983 | 23 | 0.050 |
Why?
| | Intermittent Positive-Pressure Ventilation | 1 | 1983 | 11 | 0.050 |
Why?
| | Cross Infection | 1 | 1985 | 250 | 0.050 |
Why?
| | Cholestasis | 1 | 1985 | 232 | 0.050 |
Why?
| | Femoral Fractures | 2 | 1992 | 76 | 0.050 |
Why?
| | Illinois | 2 | 2000 | 43 | 0.050 |
Why?
| | Counseling | 1 | 1986 | 388 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 2 | 2010 | 1301 | 0.050 |
Why?
| | Drug Combinations | 2 | 1997 | 343 | 0.050 |
Why?
| | Methylprednisolone | 1 | 2003 | 85 | 0.050 |
Why?
| | Citrobacter | 1 | 1982 | 2 | 0.050 |
Why?
| | Positive-Pressure Respiration | 1 | 1983 | 80 | 0.050 |
Why?
| | Diagnostic Imaging | 1 | 2005 | 328 | 0.050 |
Why?
| | Abducens Nerve Injury | 1 | 2002 | 1 | 0.050 |
Why?
| | Oculomotor Nerve Injuries | 1 | 2002 | 1 | 0.050 |
Why?
| | Cohort Studies | 3 | 2017 | 5704 | 0.050 |
Why?
| | Young Adult | 2 | 2016 | 13129 | 0.050 |
Why?
| | Enterobacteriaceae Infections | 1 | 1982 | 43 | 0.050 |
Why?
| | Radiography, Thoracic | 1 | 1983 | 167 | 0.050 |
Why?
| | Pectoralis Muscles | 1 | 1981 | 18 | 0.050 |
Why?
| | Electroretinography | 1 | 2021 | 48 | 0.040 |
Why?
| | Hydrocephalus | 1 | 1982 | 106 | 0.040 |
Why?
| | Tibial Fractures | 1 | 1982 | 68 | 0.040 |
Why?
| | Parents | 2 | 2006 | 1340 | 0.040 |
Why?
| | Patient Education as Topic | 2 | 2003 | 761 | 0.040 |
Why?
| | Medical Records | 1 | 2001 | 174 | 0.040 |
Why?
| | Infant, Premature | 2 | 2017 | 566 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2005 | 548 | 0.040 |
Why?
| | Severity of Illness Index | 2 | 2005 | 2822 | 0.040 |
Why?
| | Appendicitis | 1 | 1982 | 130 | 0.040 |
Why?
| | Cataract | 1 | 2003 | 213 | 0.040 |
Why?
| | Acute Disease | 2 | 2019 | 1007 | 0.040 |
Why?
| | Steroids | 1 | 2001 | 167 | 0.040 |
Why?
| | Administration, Oral | 2 | 2017 | 813 | 0.040 |
Why?
| | Eosinophilia | 1 | 1982 | 218 | 0.040 |
Why?
| | Therapeutic Irrigation | 1 | 1999 | 77 | 0.040 |
Why?
| | Risk | 3 | 1989 | 908 | 0.040 |
Why?
| | Colon | 1 | 1982 | 282 | 0.040 |
Why?
| | Alzheimer Disease | 1 | 2005 | 559 | 0.040 |
Why?
| | Vitreous Hemorrhage | 1 | 1999 | 5 | 0.040 |
Why?
| | Chlorambucil | 1 | 1999 | 10 | 0.040 |
Why?
| | Leukemia | 1 | 1981 | 238 | 0.040 |
Why?
| | Sodium Chloride | 1 | 1999 | 142 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 4 | 1999 | 2668 | 0.040 |
Why?
| | Physical Therapy Modalities | 1 | 1982 | 308 | 0.040 |
Why?
| | Lens, Crystalline | 1 | 1999 | 125 | 0.040 |
Why?
| | Corneal Pachymetry | 1 | 2017 | 15 | 0.040 |
Why?
| | Streptococcus pneumoniae | 1 | 1999 | 169 | 0.040 |
Why?
| | Prednisone | 1 | 1999 | 239 | 0.040 |
Why?
| | Risk Assessment | 2 | 2017 | 3434 | 0.040 |
Why?
| | Brain | 1 | 2010 | 2664 | 0.040 |
Why?
| | Blister | 1 | 2017 | 41 | 0.030 |
Why?
| | Fluorometholone | 1 | 2017 | 4 | 0.030 |
Why?
| | Administration, Intranasal | 1 | 2017 | 89 | 0.030 |
Why?
| | Biological Availability | 1 | 2017 | 148 | 0.030 |
Why?
| | Quality of Life | 2 | 2006 | 2878 | 0.030 |
Why?
| | Bone Marrow | 1 | 1999 | 286 | 0.030 |
Why?
| | Optometry | 1 | 1997 | 8 | 0.030 |
Why?
| | Intraoperative Period | 1 | 1997 | 59 | 0.030 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2017 | 33 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2018 | 183 | 0.030 |
Why?
| | Laser Coagulation | 1 | 2017 | 68 | 0.030 |
Why?
| | Administration, Topical | 1 | 1997 | 149 | 0.030 |
Why?
| | Body Weight | 1 | 2001 | 985 | 0.030 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2016 | 20 | 0.030 |
Why?
| | Battered Child Syndrome | 2 | 1992 | 6 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2004 | 1572 | 0.030 |
Why?
| | Rupture | 1 | 2016 | 92 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 156 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2016 | 173 | 0.030 |
Why?
| | Prognosis | 3 | 2020 | 4013 | 0.030 |
Why?
| | Eye | 1 | 2016 | 108 | 0.030 |
Why?
| | Uveomeningoencephalitic Syndrome | 1 | 1995 | 7 | 0.030 |
Why?
| | Apoptosis | 2 | 2016 | 2552 | 0.030 |
Why?
| | Sarcoidosis | 1 | 2017 | 159 | 0.030 |
Why?
| | Surgical Wound Dehiscence | 1 | 1994 | 22 | 0.030 |
Why?
| | Agenesis of Corpus Callosum | 1 | 1994 | 12 | 0.030 |
Why?
| | Scotoma | 1 | 1994 | 5 | 0.030 |
Why?
| | Choroid Diseases | 1 | 1994 | 10 | 0.030 |
Why?
| | Pilot Projects | 1 | 2000 | 1693 | 0.030 |
Why?
| | Choroiditis | 1 | 1994 | 6 | 0.030 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2017 | 253 | 0.030 |
Why?
| | Accidents, Home | 1 | 2013 | 31 | 0.030 |
Why?
| | Ophthalmoplegia | 1 | 1993 | 8 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 1993 | 46 | 0.030 |
Why?
| | Contraindications | 1 | 1993 | 90 | 0.030 |
Why?
| | Facial Paralysis | 1 | 1993 | 22 | 0.030 |
Why?
| | Tamoxifen | 1 | 1994 | 202 | 0.030 |
Why?
| | Iris | 1 | 1993 | 19 | 0.030 |
Why?
| | Surgery, Plastic | 1 | 1994 | 45 | 0.030 |
Why?
| | Dark Adaptation | 1 | 2013 | 13 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1225 | 0.030 |
Why?
| | Aviation | 1 | 2013 | 8 | 0.030 |
Why?
| | Mass Screening | 1 | 2021 | 1267 | 0.020 |
Why?
| | Fungemia | 1 | 1992 | 4 | 0.020 |
Why?
| | Cranial Fossa, Posterior | 1 | 1992 | 18 | 0.020 |
Why?
| | Ocular Physiological Phenomena | 1 | 1992 | 9 | 0.020 |
Why?
| | Aspergillosis | 1 | 1992 | 22 | 0.020 |
Why?
| | Candidiasis | 1 | 1992 | 56 | 0.020 |
Why?
| | Eye Diseases | 1 | 1993 | 87 | 0.020 |
Why?
| | Irritants | 1 | 2012 | 43 | 0.020 |
Why?
| | Vision Disorders | 1 | 1993 | 141 | 0.020 |
Why?
| | Emergencies | 2 | 2009 | 164 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2018 | 547 | 0.020 |
Why?
| | Models, Statistical | 1 | 2016 | 668 | 0.020 |
Why?
| | Mycoses | 1 | 1992 | 79 | 0.020 |
Why?
| | Vision Disparity | 1 | 1991 | 3 | 0.020 |
Why?
| | Heparin | 1 | 2013 | 259 | 0.020 |
Why?
| | Radiography | 3 | 1985 | 822 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2052 | 0.020 |
Why?
| | Thrombocytopenia | 1 | 2013 | 198 | 0.020 |
Why?
| | Sex Factors | 3 | 1987 | 2064 | 0.020 |
Why?
| | Aged, 80 and over | 4 | 2005 | 7593 | 0.020 |
Why?
| | Coloboma | 1 | 1990 | 5 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2012 | 1089 | 0.020 |
Why?
| | Pigment Epithelium of Eye | 1 | 1990 | 35 | 0.020 |
Why?
| | Retinal Perforations | 1 | 1990 | 16 | 0.020 |
Why?
| | Safflower Oil | 1 | 1990 | 5 | 0.020 |
Why?
| | Crohn Disease | 1 | 1994 | 244 | 0.020 |
Why?
| | Light Coagulation | 1 | 1990 | 8 | 0.020 |
Why?
| | Soybean Oil | 1 | 1990 | 14 | 0.020 |
Why?
| | Sacroiliac Joint | 2 | 1994 | 33 | 0.020 |
Why?
| | Emulsions | 1 | 1990 | 53 | 0.020 |
Why?
| | HEPES | 1 | 1989 | 2 | 0.020 |
Why?
| | Chondroitin | 1 | 1989 | 5 | 0.020 |
Why?
| | Tissue Preservation | 1 | 1989 | 12 | 0.020 |
Why?
| | Lung | 1 | 1983 | 4063 | 0.020 |
Why?
| | Propionibacterium acnes | 1 | 1989 | 10 | 0.020 |
Why?
| | Chondroitin Sulfates | 1 | 1989 | 32 | 0.020 |
Why?
| | Circadian Rhythm | 1 | 1993 | 469 | 0.020 |
Why?
| | Nocardia asteroides | 1 | 1989 | 1 | 0.020 |
Why?
| | Sulfacetamide | 1 | 1989 | 1 | 0.020 |
Why?
| | Trimethoprim | 1 | 1989 | 7 | 0.020 |
Why?
| | Sulfamethoxazole | 1 | 1989 | 7 | 0.020 |
Why?
| | Gentamicins | 1 | 1989 | 54 | 0.020 |
Why?
| | Indians, North American | 1 | 1995 | 629 | 0.020 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 1989 | 42 | 0.020 |
Why?
| | Graft Rejection | 1 | 1992 | 620 | 0.020 |
Why?
| | Antioxidants | 1 | 2012 | 584 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1773 | 0.020 |
Why?
| | Phospholipids | 1 | 1990 | 222 | 0.020 |
Why?
| | Anticoagulants | 1 | 2013 | 664 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2016 | 2476 | 0.020 |
Why?
| | Forensic Medicine | 1 | 2007 | 18 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 1990 | 209 | 0.020 |
Why?
| | Brain Injuries | 1 | 1992 | 494 | 0.020 |
Why?
| | Recurrence | 1 | 1990 | 1055 | 0.020 |
Why?
| | Piperazines | 1 | 1989 | 350 | 0.020 |
Why?
| | Orbit Evisceration | 1 | 2006 | 1 | 0.020 |
Why?
| | Forensic Pathology | 1 | 2006 | 7 | 0.020 |
Why?
| | Dacryocystorhinostomy | 1 | 2006 | 10 | 0.020 |
Why?
| | Hawaii | 1 | 1986 | 32 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2006 | 56 | 0.020 |
Why?
| | Chromosome Disorders | 1 | 1986 | 43 | 0.020 |
Why?
| | Evaluation Studies as Topic | 1 | 1986 | 180 | 0.020 |
Why?
| | Mutation | 1 | 2017 | 3947 | 0.020 |
Why?
| | Klebsiella pneumoniae | 1 | 1985 | 47 | 0.020 |
Why?
| | Wounds, Nonpenetrating | 1 | 2009 | 276 | 0.020 |
Why?
| | Informed Consent | 1 | 1986 | 172 | 0.010 |
Why?
| | Hirschsprung Disease | 1 | 1985 | 87 | 0.010 |
Why?
| | Tablets | 1 | 1984 | 40 | 0.010 |
Why?
| | Abdominal Muscles | 1 | 1983 | 5 | 0.010 |
Why?
| | Penicillin Resistance | 1 | 1983 | 8 | 0.010 |
Why?
| | Mitral Valve | 1 | 1984 | 88 | 0.010 |
Why?
| | Ulcer | 1 | 1984 | 32 | 0.010 |
Why?
| | Arthritis, Infectious | 1 | 1985 | 69 | 0.010 |
Why?
| | Meningitis, Haemophilus | 1 | 1983 | 6 | 0.010 |
Why?
| | Hernia, Umbilical | 1 | 1983 | 17 | 0.010 |
Why?
| | Arthritis, Rheumatoid | 1 | 1992 | 1167 | 0.010 |
Why?
| | Length of Stay | 1 | 1989 | 1205 | 0.010 |
Why?
| | Haemophilus influenzae | 1 | 1983 | 63 | 0.010 |
Why?
| | Health Services Misuse | 1 | 1983 | 33 | 0.010 |
Why?
| | Angiostrongylus | 1 | 1982 | 1 | 0.010 |
Why?
| | Nematode Infections | 1 | 1982 | 5 | 0.010 |
Why?
| | Age Distribution | 1 | 2003 | 390 | 0.010 |
Why?
| | Feces | 1 | 1985 | 481 | 0.010 |
Why?
| | Infant, Premature, Diseases | 1 | 1983 | 100 | 0.010 |
Why?
| | Rupture, Spontaneous | 1 | 1982 | 17 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2005 | 1316 | 0.010 |
Why?
| | Contracture | 1 | 1982 | 20 | 0.010 |
Why?
| | Kidney | 1 | 1990 | 1467 | 0.010 |
Why?
| | Leukemia, Lymphoid | 1 | 1981 | 27 | 0.010 |
Why?
| | Enema | 1 | 1982 | 47 | 0.010 |
Why?
| | Attitude of Health Personnel | 2 | 1987 | 1163 | 0.010 |
Why?
| | Age Factors | 1 | 1989 | 3286 | 0.010 |
Why?
| | Elbow Joint | 1 | 1982 | 71 | 0.010 |
Why?
| | Glucagon | 1 | 1982 | 109 | 0.010 |
Why?
| | Regression Analysis | 1 | 2003 | 1022 | 0.010 |
Why?
| | Skin | 1 | 1985 | 751 | 0.010 |
Why?
| | Hip Joint | 1 | 1982 | 171 | 0.010 |
Why?
| | Contrast Media | 1 | 1982 | 462 | 0.010 |
Why?
| | Knee Joint | 1 | 1982 | 409 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2006 | 5424 | 0.010 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 1981 | 622 | 0.010 |
Why?
| | Spasm | 1 | 1994 | 20 | 0.010 |
Why?
| | Spondylitis | 1 | 1994 | 2 | 0.010 |
Why?
| | Tenosynovitis | 1 | 1994 | 11 | 0.010 |
Why?
| | Sulfasalazine | 1 | 1994 | 23 | 0.010 |
Why?
| | Crystallization | 1 | 1994 | 141 | 0.010 |
Why?
| | Cadaver | 1 | 1994 | 296 | 0.010 |
Why?
| | Middle East | 1 | 1993 | 15 | 0.010 |
Why?
| | Accommodation, Ocular | 1 | 1993 | 10 | 0.010 |
Why?
| | Rib Fractures | 1 | 1992 | 32 | 0.010 |
Why?
| | Posture | 1 | 1993 | 186 | 0.010 |
Why?
| | Muscles | 1 | 1993 | 325 | 0.010 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 1994 | 350 | 0.010 |
Why?
| | Reference Values | 1 | 1992 | 816 | 0.010 |
Why?
| | Postoperative Care | 1 | 1991 | 261 | 0.000 |
Why?
| | Drug Contamination | 1 | 1989 | 53 | 0.000 |
Why?
| | Culture Media | 1 | 1989 | 165 | 0.000 |
Why?
| | Macular Degeneration | 1 | 1990 | 164 | 0.000 |
Why?
| | Technetium Tc 99m Medronate | 1 | 1985 | 3 | 0.000 |
Why?
| | Suppuration | 1 | 1985 | 9 | 0.000 |
Why?
| | Gallium Radioisotopes | 1 | 1985 | 14 | 0.000 |
Why?
| | Radionuclide Imaging | 1 | 1985 | 118 | 0.000 |
Why?
| | Breast Neoplasms | 1 | 1994 | 2234 | 0.000 |
Why?
| | Aging | 1 | 1990 | 1864 | 0.000 |
Why?
| | Pediatrics | 1 | 1987 | 1094 | 0.000 |
Why?
|
|
Enzenauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|